secwatch.observer — SEC 8-K summary
======================================

Issuer:     RetinalGenix Technologies Inc. (RTGN)
CIK:        0001836295
Form:       8-K
Filed at:   2022-07-07T23:59:59+00:00
Accession:  0001493152-22-018761
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 2.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RetinalGenix acquires DNA/GPS for 2M shares; combines retinal imaging with genetic mapping
--------------------------------------------------------------------------------

- Acquired all outstanding shares of DNA/GPS Inc. in exchange for 2,000,000 shares of RTGN common stock.
- DNA/GPS is a pharmacogenetics company based in Tampa, FL, founded by Dr. Lawrence Perich.
- Combined platform aims to enable home-based screening and diagnosis of systemic diseases like heart disease, Alzheimer's, Parkinson's.
- Dr. Perich to join advisory board; platform expected to reduce reliance on costly procedures like CT, MRI, PET.
- Shares issued in private placement exempt from registration under Section 4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1836295/000149315222018761/0001493152-22-018761-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1836295/000149315222018761/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-018761

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer